Can a 3-year-old use Pataday (olopatadine) eye drops?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pataday (olopatadine) eye drops are not recommended for children under 3 years old without a doctor's supervision, and for 3-year-olds, the medication may be used but only under the direction of a pediatrician or eye specialist. The standard formulation (0.1% or 0.2%) is typically dosed as one drop in each affected eye once or twice daily, depending on the concentration, as seen in the classification of dual action agents that possess both antihistamine and mast cell stabilizer activities 1. When administering eye drops to a young child, it is essential to follow proper technique: have them lie down or tilt their head back, gently pull down the lower eyelid to create a small pocket, place the drop in this pocket (not directly on the eyeball), and have them keep their eyes closed for 1-2 minutes afterward to allow absorption.

Key Considerations

  • Pataday works by blocking histamine receptors to reduce allergic eye symptoms like itching and redness, which is crucial for managing ocular allergy symptoms in children 1.
  • Since children's bodies process medications differently than adults, professional medical guidance is essential to determine the appropriate dosage and ensure the benefits outweigh any potential risks for your 3-year-old's specific condition.
  • The use of olopatadine eye drops has been associated with a relative value of 1.0 point when combining symptom and medication scores, indicating its efficacy in treating allergic rhinoconjunctivitis 1.

Administration and Monitoring

  • It is crucial to monitor the child's response to the medication and adjust the dosage as needed under the guidance of a pediatrician or eye specialist.
  • Parents or caregivers should be aware of potential side effects and report any concerns to the child's healthcare provider promptly.

From the FDA Drug Label

Directions adults and children 2 years of age and older: put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age:consult a doctor The answer is yes, a 3 year old can use pataday drops, as the label indicates that the product can be used in children 2 years of age and older 2.

From the Research

Usage of Pataday Drops in Children

  • The usage of Pataday drops, which contain olopatadine, in children is approved for patients aged 3 years and above 3.
  • Olopatadine is available in various formulations, including Patanol and Pataday, and is used to treat allergic conjunctivitis 4.
  • Pataday is a once-daily formulation of olopatadine, marketed for the treatment of itching associated with allergic conjunctivitis 5.

Safety and Efficacy in Children

  • Studies have established the efficacy, safety, and comfort of olopatadine in several study design models and comparisons to other antiallergy medications 3.
  • Olopatadine has been shown to be significantly more effective than placebos in relieving the symptoms of allergic rhinoconjunctivitis 6, 7.
  • The safety profile of olopatadine has been demonstrated in various clinical trials, with minimal adverse effects reported 4, 5.

Age-Specific Considerations

  • The approved age range for the use of olopatadine, including Pataday drops, is 3 years and above 3.
  • There is no specific information available on the use of Pataday drops in children under the age of 3 years in the provided studies.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.